ES402285A1 - Procedimiento para la obtencion de composiciones farmaceu- ticas con actividad fibrinolitica o antifibrinolitica. - Google Patents
Procedimiento para la obtencion de composiciones farmaceu- ticas con actividad fibrinolitica o antifibrinolitica.Info
- Publication number
- ES402285A1 ES402285A1 ES402285A ES402285A ES402285A1 ES 402285 A1 ES402285 A1 ES 402285A1 ES 402285 A ES402285 A ES 402285A ES 402285 A ES402285 A ES 402285A ES 402285 A1 ES402285 A1 ES 402285A1
- Authority
- ES
- Spain
- Prior art keywords
- fibrinolysis
- derivative
- fibrinolytic
- methoxyl
- syndromes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000020764 fibrinolysis Effects 0.000 title abstract 2
- 230000001939 inductive effect Effects 0.000 title 1
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 abstract 1
- 125000000339 4-pyridyl group Chemical class N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000000460 chlorine Chemical group 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000001907 coumarones Chemical class 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000003527 fibrinolytic agent Substances 0.000 abstract 1
- 230000003480 fibrinolytic effect Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1227771 | 1971-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES402285A1 true ES402285A1 (es) | 1975-03-16 |
Family
ID=10001598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES402285A Expired ES402285A1 (es) | 1971-04-29 | 1972-04-29 | Procedimiento para la obtencion de composiciones farmaceu- ticas con actividad fibrinolitica o antifibrinolitica. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US3810991A (es) |
| AR (1) | AR192932A1 (es) |
| AT (1) | AT319243B (es) |
| AU (1) | AU456733B2 (es) |
| BE (1) | BE782604A (es) |
| CA (1) | CA971481A (es) |
| CH (1) | CH540930A (es) |
| DE (1) | DE2220361A1 (es) |
| DK (1) | DK139871B (es) |
| ES (1) | ES402285A1 (es) |
| FR (1) | FR2134435B1 (es) |
| GB (1) | GB1335403A (es) |
| IE (1) | IE36278B1 (es) |
| NL (1) | NL7205784A (es) |
| NO (1) | NO135788C (es) |
| OA (1) | OA04005A (es) |
| SE (1) | SE392104B (es) |
| ZA (1) | ZA722478B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4851554A (en) * | 1987-04-06 | 1989-07-25 | University Of Tennessee Research Corporation | Certain 3-substituted 2-alkyl benzofuran derivatives |
| US4806663A (en) * | 1987-04-06 | 1989-02-21 | The University Of Tennessee Research Corporation | Certain 3-substituted 2-alkyl benzofuran derivatives |
| US4831156A (en) * | 1987-09-30 | 1989-05-16 | The University Of Tennessee Research Corp. | 3-substituted 2-alkyl indole derivatives |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL136620C (es) * | 1963-04-30 | |||
| GB1245283A (en) * | 1968-10-04 | 1971-09-08 | Labaz | Pyrazole derivatives |
-
1971
- 1971-04-29 GB GB1227771A patent/GB1335403A/en not_active Expired
-
1972
- 1972-04-11 IE IE473/72A patent/IE36278B1/xx unknown
- 1972-04-13 ZA ZA722478A patent/ZA722478B/xx unknown
- 1972-04-17 US US00244495A patent/US3810991A/en not_active Expired - Lifetime
- 1972-04-19 AU AU41318/72A patent/AU456733B2/en not_active Expired
- 1972-04-20 AR AR241576A patent/AR192932A1/es active
- 1972-04-24 FR FR7214422A patent/FR2134435B1/fr not_active Expired
- 1972-04-25 BE BE782604A patent/BE782604A/xx unknown
- 1972-04-26 CH CH618172A patent/CH540930A/fr not_active IP Right Cessation
- 1972-04-26 DE DE19722220361 patent/DE2220361A1/de active Pending
- 1972-04-27 DK DK210272AA patent/DK139871B/da unknown
- 1972-04-28 OA OA54553A patent/OA04005A/xx unknown
- 1972-04-28 NO NO1507/72A patent/NO135788C/no unknown
- 1972-04-28 SE SE7205672A patent/SE392104B/xx unknown
- 1972-04-28 AT AT373872A patent/AT319243B/de not_active IP Right Cessation
- 1972-04-28 CA CA141,147A patent/CA971481A/en not_active Expired
- 1972-04-28 NL NL7205784A patent/NL7205784A/xx not_active Application Discontinuation
- 1972-04-29 ES ES402285A patent/ES402285A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CH540930A (fr) | 1973-08-31 |
| FR2134435B1 (es) | 1976-04-16 |
| FR2134435A1 (es) | 1972-12-08 |
| OA04005A (fr) | 1979-09-15 |
| IE36278B1 (en) | 1976-09-29 |
| ZA722478B (en) | 1972-12-27 |
| NO135788C (es) | 1977-06-01 |
| GB1335403A (en) | 1973-10-31 |
| NO135788B (es) | 1977-02-21 |
| IE36278L (en) | 1972-10-29 |
| AU456733B2 (en) | 1974-12-06 |
| BE782604A (fr) | 1972-10-25 |
| DE2220361A1 (de) | 1972-11-02 |
| NL7205784A (es) | 1972-10-31 |
| AU4131872A (en) | 1973-10-25 |
| DK139871C (es) | 1979-10-08 |
| DK139871B (da) | 1979-05-07 |
| US3810991A (en) | 1974-05-14 |
| AT319243B (de) | 1974-12-10 |
| SE392104B (sv) | 1977-03-14 |
| AR192932A1 (es) | 1973-03-21 |
| CA971481A (en) | 1975-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES399497A1 (es) | Procedimiento para la obtencion de p-mentano - 3 - carbosa-midas n - sustituidas. | |
| GB1331405A (en) | Esters their production and their medicinal use | |
| ES436314A1 (es) | Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3-alquinilaminopropanos. | |
| ES421430A1 (es) | Procedimiento para producir derivados carbostirilo. | |
| ES431020A1 (es) | Procedimiento para la preparacion de derivados de 1,4-dihi- dro-2h-isoquinoleina. | |
| GB1374299A (en) | Derivatives of 1,2,3,4-tetrahydroisoquinoline production of the same and composition thereof | |
| ES402285A1 (es) | Procedimiento para la obtencion de composiciones farmaceu- ticas con actividad fibrinolitica o antifibrinolitica. | |
| GB1389504A (en) | 2-amino-1,4-dihydropyridines their production and their medicinal use | |
| ES411038A1 (es) | Un procedimiento para la preparacion de compuestos semisin-teticos intermedios en la produccion de cefalosporinas, pe- nicilinas y antibioticos relacionados de beta-lactama. | |
| ES340204A1 (es) | Procedimiento para producir compuestos de ferroceno. | |
| ES432027A1 (es) | Un procedimiento para la preparacion de anilinobenzotiazo- les. | |
| ES431673A1 (es) | Un procedimiento para la preparacion de compuestos de 7- acilamido-7-metoxi-cefalosporina. | |
| ES417396A1 (es) | Un procedimiento para la produccion de una composicion far-maceutica. | |
| ES397787A1 (es) | Procedimiento para la obtencion de derivados del indol con propiedades farmaceuticas. | |
| ES411563A1 (es) | Procedimiento para la produccion de colorantes de camarina y de cumarinimida. | |
| ES441434A1 (es) | Proceso de obtencion de derivados del acido 2-naftil-butiri-co de actividad terapeutica. | |
| ES392848A1 (es) | Un procedimiento para la preparacion de nuevos derivados de indenopirrol. | |
| ES8505653A1 (es) | Procedimiento para preparar un n-alquil-(3 o 4)piperidinil benzoato | |
| JPS5170769A (en) | 10*111 jihidoro 33 karubokishishipuroheputajin oyobi sono nn okisaido | |
| FR2137626A1 (en) | 6-(benzazepine-6-yl) benzoic acid salts-intermediates for - rheadan alkaloids | |
| ES443288A1 (es) | Procedimiento para la preparacion de penicilinas. | |
| ES415424A1 (es) | Procedimiento de preparacion de derivados heterociclicos. | |
| ES395875A1 (es) | Un procedimiento para la preparacion de derivados de indol. | |
| ES405281A1 (es) | Un procedimiento para preparar nuevos compuestos de cefa- losporina. | |
| FR2217009A1 (en) | 2-Tetrazole analogs of prostaglandins - with bronchodilatory, antihyperten-sive and gastric secretion inhibiting activity |